THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE - A NEW PREPARATIVE REGIMEN FOR AUTOLOGOUS MARROW OR BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA

被引：1
|
作者：
DIMOPOULOS, MA [1 ]
ALEXANIAN, R [1 ]
PRZEPIORKA, D [1 ]
HESTER, J [1 ]
ANDERSSON, B [1 ]
GIRALT, S [1 ]
MEHRA, R [1 ]
VANBESIEN, K [1 ]
DELASALLE, KB [1 ]
READING, C [1 ]
DEISSEROTH, AB [1 ]
CHAMPLIN, RE [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT HEMATOL,BONE MARROW TRANSPLANTAT SECT,HOUSTON,TX 77030
来源：
BLOOD | 1993年 / 82卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2324 / 2328
页数：5
相关论文
共 50 条
  • [21] COST OF INTENSIVE THERAPY FOLLOWED BY AUTOLOGOUS BLOOD STEM-CELL - TRANSPLANTATION IN MULTIPLE-MYELOMA
    CALLAERT, S
    RAVAUD, P
    VIENSBITKER, C
    DREYFUS, F
    HAZEBROUCQ, G
    AMOR, B
    BROUET, JC
    FERMAND, JP
    PRESSE MEDICALE, 1994, 23 (15): : 694 - 698
  • [22] AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF THE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION
    BJORKSTRAND, B
    LJUNGMAN, P
    BIRD, JM
    SAMSON, D
    BRANDT, L
    ALEGRE, A
    AUZANNEAU, G
    BLADE, J
    BRUNET, S
    CARLSON, K
    CAVO, M
    FERRANT, A
    GRAVETT, P
    DELAURENZI, A
    PRENTICE, HG
    PROCTOR, S
    REMES, K
    TROUSSARD, X
    VERDONCK, LF
    WILLIAMS, C
    GAHRTON, G
    STEM CELLS, 1995, 13 : 140 - 146
  • [23] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [24] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 116 - 117
  • [25] RAPID ENGRAFTMENT FOLLOWING BUSULFAN CYCLOPHOSPHAMIDE AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR HIGH-RISK HEMATOLOGICAL MALIGNANCIES
    BALLESTER, O
    JANSSEN, W
    ELFENBEIN, G
    FIELDS, K
    HIEMENZ, J
    ZORSKY, P
    KRONISH, L
    BEACH, B
    FOODY, M
    SHERMAN, M
    BLOOD, 1993, 82 (10) : A626 - A626
  • [26] ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE FOR PATIENTS WITH MULTIPLE-MYELOMA
    BUCKNER, CD
    APPELBAUM, FA
    STORB, R
    CLIFT, FA
    HANSEN, J
    BENSINGER, WI
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1131 - 1131
  • [27] PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    RAJE, N
    POWLES, R
    MEHTA, J
    SINGHAL, S
    MILAN, S
    HORTON, C
    VINER, C
    TRELEAVEN, J
    BLOOD, 1994, 84 (10) : A719 - A719
  • [28] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [29] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [30] AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER FIRST REMISSION INDUCTION TREATMENT IN MULTIPLE-MYELOMA - A REPORT OF THE FRENCH REGISTRY ON AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA
    HAROUSSEAU, JL
    ATTAL, M
    DIVINE, M
    MARIT, G
    LEBLOND, V
    STOPPA, AM
    BOURHIS, JH
    CAILLOT, D
    BOASSON, M
    ABGRALL, JF
    FACON, T
    LINASSIER, C
    CAHN, JY
    LAMY, T
    TROUSSARD, X
    GRATECOS, N
    PIGNON, B
    AUZANNEAU, G
    BATAILLE, R
    STEM CELLS, 1995, 13 : 132 - 139
12345